title: What do policy makers need to know? Lessons from the decision to add pneumococcal conjugate and rotavirus vaccines to the US immunization program.
authors.affiliation: National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA. cwhitney@cdc.gov
authors.forename: Cynthia G
authors.initials: CG
authors.lastname: Whitney
authors.forename: Umesh D
authors.initials: UD
authors.lastname: Parashar
mesh_terms: D026683:Advisory Committees; D002487:Centers for Disease Control and Prevention, U.S.; D003362:Cost-Benefit Analysis; D003657:Decision Making; D055317:Evidence-Based Practice; D006291:Health Policy; D006801:Humans; D017589:Immunization Programs / Q000191:economics / Q000458:organization & administration*; D022242:Pneumococcal Vaccines; D022243:Rotavirus Vaccines; D014481:United States; D018074:Vaccines, Conjugate
chemical_list: D022242:Pneumococcal Vaccines; D022243:Rotavirus Vaccines; D018074:Vaccines, Conjugate